130 related articles for article (PubMed ID: 7801430)
1. Diagnostic and prognostic importance of chromosomal aberrations identified in 61 dogs with lymphosarcoma.
Hahn KA; Richardson RC; Hahn EA; Chrisman CL
Vet Pathol; 1994 Sep; 31(5):528-40. PubMed ID: 7801430
[TBL] [Abstract][Full Text] [Related]
2. Chromosome studies in canine lymphosarcoma.
Basrur PK; Gilman JP
Cornell Vet; 1966 Jul; 56(3):451-69. PubMed ID: 6013171
[No Abstract] [Full Text] [Related]
3. Cutaneous lymphosarcoma with abnormal chromosomes in a dog.
Swayne DE; Michalski K; McCaw D
J Comp Pathol; 1987 Sep; 97(5):609-14. PubMed ID: 3680650
[TBL] [Abstract][Full Text] [Related]
4. Correlations between numerical chromosomal aberrations in the tumor and peripheral blood in canine lymphoma.
Devitt JJ; Maranon DG; Ehrhart EJ; Bachand AM; Lana SE; LaRue SM
Cytogenet Genome Res; 2009; 124(1):12-8. PubMed ID: 19372664
[TBL] [Abstract][Full Text] [Related]
5. Histologic classification as a prognostic criterion for canine lymphosarcoma.
Weller RE; Holmberg CA; Theilen GH; Madewell BR
Am J Vet Res; 1980 Aug; 41(8):1310-4. PubMed ID: 6893792
[TBL] [Abstract][Full Text] [Related]
6. Carmustine, vincristine, and prednisone in the treatment of canine lymphosarcoma.
Ricci Lucas SR; Pereira Coelho BM; Marquezi ML; Franchini ML; Miyashiro SI; De Benedetto Pozzi DH
J Am Anim Hosp Assoc; 2004; 40(4):292-9. PubMed ID: 15238559
[TBL] [Abstract][Full Text] [Related]
7. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
[TBL] [Abstract][Full Text] [Related]
8. [Cytogenetic studies in patients with non-Hodgkin's lymphoma (nHL)].
Haus O; Kozłowska J; Zubkiewicz L; Jagielski J; Kotlarek-Haus S
Pol Arch Med Wewn; 1991 Sep; 86(3):132-41. PubMed ID: 1808598
[TBL] [Abstract][Full Text] [Related]
9. Karyotype and prognosis in non-Hodgkin lymphoma.
Pirc-Danoewinata H; Chott A; Onderka E; Drach J; Schlögl E; Jäger U; Thalhammer F; Nowotny H; Aryee D; Steger GG
Leukemia; 1994 Nov; 8(11):1929-39. PubMed ID: 7967739
[TBL] [Abstract][Full Text] [Related]
10. Correlation between thoracic radiographic changes and remission/survival duration in 270 dogs with lymphosarcoma.
Starrak GS; Berry CR; Page RL; Johnson JL; Thrall DE
Vet Radiol Ultrasound; 1997; 38(6):411-8. PubMed ID: 9402705
[TBL] [Abstract][Full Text] [Related]
11. Observations on the chromosomes of a lymphosarcoma in a dog.
Idowu L
Vet Rec; 1976 Aug; 99(6):103. PubMed ID: 989649
[No Abstract] [Full Text] [Related]
12. Cytogenetic abnormalities predict clinical outcome in non-Hodgkin lymphoma.
Levine EG; Arthur DC; Frizzera G; Peterson BA; Hurd DD; Bloomfield CD
Ann Intern Med; 1988 Jan; 108(1):14-20. PubMed ID: 3337492
[TBL] [Abstract][Full Text] [Related]
13. A prospective survey of familial canine lymphosarcoma.
Onions DE
J Natl Cancer Inst; 1984 Apr; 72(4):909-12. PubMed ID: 6584665
[TBL] [Abstract][Full Text] [Related]
14. DNA ploidy and cell kinetic characteristics in canine non-Hodgkin's lymphoma.
Teske E; Rutteman GR; Kuipers-Dijkshoorn NJ; van Dierendonck JH; van Heerde P; Cornelisse CJ
Exp Hematol; 1993 Apr; 21(4):579-84. PubMed ID: 8462667
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy for canine lymphosarcoma.
Madewell BR
Am J Vet Res; 1975 Oct; 36(10):1525-8. PubMed ID: 1242622
[TBL] [Abstract][Full Text] [Related]
16. Reevaluation of the University of Wisconsin 2-year protocol for treating canine lymphosarcoma.
Kaiser CI; Fidel JL; Roos M; Kaser-Hotz B
J Am Anim Hosp Assoc; 2007; 43(2):85-92. PubMed ID: 17339285
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of pyridoxine to ameliorate the cutaneous toxicity associated with doxorubicin containing pegylated (Stealth) liposomes: a randomized, double-blind clinical trial using a canine model.
Vail DM; Chun R; Thamm DH; Garrett LD; Cooley AJ; Obradovich JE
Clin Cancer Res; 1998 Jun; 4(6):1567-71. PubMed ID: 9626479
[TBL] [Abstract][Full Text] [Related]
18. Splenic and hepatic ultrasound and cytology in canine lymphoma: effects of findings on stage migration and assessment of prognosis.
Nerschbach V; Eberle N; Joetzke AE; Hoeinghaus R; Hungerbuehler S; Mischke R; Nolte I; Betz D
Vet Comp Oncol; 2016 Aug; 14 Suppl 1():82-94. PubMed ID: 25470748
[TBL] [Abstract][Full Text] [Related]
19. Levamisole as adjuvant to chemotherapy for canine lymphosarcoma.
MacEwen EG; Hayes AA; Mooney S; Patnaik A; Kurzman I; Hardy WD
J Biol Response Mod; 1985 Aug; 4(4):427-33. PubMed ID: 3839843
[TBL] [Abstract][Full Text] [Related]
20. Chemoimmunotherapy for canine lymphosarcoma.
Theilen GH; Worley M; Benjamini E
J Am Vet Med Assoc; 1977 Mar; 170(6):607-10. PubMed ID: 576595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
